Maine is set to receive $26 million as part of a nationwide, $7.4 billion settlement with Purdue Pharma and its owners, the Sackler family, the Maine Attorney General’s Office confirmed Wednesday.

The settlement still has to be finalized by a federal bankruptcy court in New York, but so far 49 states and six U.S. territories agreed to the terms of the settlement over Purdue Pharma’s role in overprescribing opioid painkillers. Oklahoma, the only state not in the agreement, reached a separate settlement with Purdue Pharma in 2019.

Payouts for the parties in the settlement would occur over the next 15 years. As part of the agreement, the Sackler family would end its ownership stakes in Purdue Pharma.

Overuse of opioid pills contributed to the nationwide opioid crisis, the fallout of which the nation is still recovering from. Maine’s drug overdose deaths fell two years in a row, dropping to 490 in 2024 after peaking at 723 deaths in 2022.

The Maine Attorney General’s Office said on Wednesday that it did not have an immediate comment on the settlement.

The Purdue Pharma settlement is the latest in a series of lawsuit settlements rooted in drug companies downplaying the risks associated with prescribing opioids. The other settlements have totaled $50 billion across the nation, The Associated Press reported.